Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
EvenUp Introduces Express Demands, the First in its Series of AI Documents
-
CORRECTION – Leaders from Marriott, Accor, IHG, Hyatt and Radisson to Unite to Shape the Future of the Hospitality Industry at Questex’s IHIF EMEA 2025
-
Neinor Homes and Ameris create a joint-venture to invest up to €50mn in the Spanish residential sector
-
Neinor Homes and Ameris create a joint-venture to invest up to €50mn in the Spanish residential sector
-
Qmerit, Wisetack Enter Partnership to Give EV Buyers Greater Flexibility in Financing Home Charging
-
Form D Bain Capital Insurance
-
Creator Marketing Platform ShopMy Raises $77.5M to Pioneer Performance-First Approach
-
KKR Extends Second Tender Offer for FUJI SOFT to Early February
-
VXI Global Solutions Announces Ryan Collins as Chief Operating Officer
-
Consilio Appoints Todd Herndon as Chief Financial Officer
-
Transom Capital Adds Mads Jorge to Investment Leadership Team
-
Leaders from Marriott, Accor, IHG, Hyatt and Radisson to Unite to Shape the Future of the Hospitality Industry at Questex’s IHIF EMEA 2025
-
Form SCHEDULE 13D/A Redwire Corp Filed by: BAIN CAPITAL CREDIT MEMBER, LLC
-
Bain matches CC Capital's offer for Australia's Insignia Financial at $1.92 billion
-
Rocket Software Introduces Phishing-Resistant Solution for Secure Host Connectivity
-
Form D/A Bain Capital Global Dire
-
Envestnet Announces Chris Todd as Chief Executive Officer
-
Redwire Corporation (RDW) Announces Acquisition of Edge Autonomy
-
Redwire Announces Acquisition of Edge Autonomy; Transformational Transaction Creates a Multi-Domain, Scaled and Profitable Space and Defense Tech Company
-
Mitsubishi Chemical picks Bain as preferred bidder for pharma unit, sources say
-
Kantar Group announces the proposed sale of Kantar Media
-
The Mutual Group Appoints Julie Brown as Vice President, Head of Product and Underwriting Services
-
BILL Holdings (BILL) Appoints Keri Gohman and Dan Wernikoff to its Board
-
Industry Leaders Keri Gohman and Dan Wernikoff Join BILL Board of Directors
-
Form 4 Olema Pharmaceuticals, For: Jan 08 Filed by: Bain Capital Life Sciences Fund IV, L.P.
-
Form 3 Olema Pharmaceuticals, For: Jan 08 Filed by: Bain Capital Life Sciences Fund IV, L.P.
-
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P.
-
Wisetack Partners With U.S. Bank to Expand Embedded Pay-Over-Time Financing Options in Home Services
-
Bakery franchise chain Crumbl explores $2 billion sale, sources say
-
Suvoda and Greenphire to Merge Creating a Technology Platform Optimizing Clinical Trial Processes and Streamlining the Patient Journey
-
Healthcare dealmakers eye M&A resurgence in second Trump term
-
Bain Capital raises bid for Australia's Insignia to $1.8 billion, matches CC Capital
-
Apollo considers $9.5 billion investment in Seven & i buyout, Bloomberg says
-
Timberlyne Therapeutics Launches with a $180 Million Series A Financing to Advance CM313, a Potentially Best-in-Class Anti-CD38 Monoclonal Antibody, for Diseases of High Unmet Medical Needs
-
Valeo Foods Group Completes the Acquisition of I.D.C. Holding
-
Valspring Capital Successfully Closes Fund I Above Target at $255 Million
-
Alkeus Pharmaceuticals Announces New Positive Interim TEASE-3 Study Results Showing Gildeuretinol Prevented Disease Progression in Early-Stage Stargardt Patients
-
Areteia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday January 14, 2025
-
KKR Further Extends Second Tender Offer for FUJI SOFT
-
Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies
-
Seven & i, at centre of M&A tussle, sees quarterly profit tumble
-
Surf Internet Celebrates 25 Years of Innovation and Connection
-
Veza Recognized in the Gartner Peer Insights Voice of the Customer Report for Identity Governance and Administration (IGA)
-
Alkeus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Form SCHEDULE 13D/A Bain Capital Private Filed by: Bain Capital SIP Investments, LP
-
KKR asks Fuji Soft to file injunction against Bain's 'breach of NDA'
-
Australia's Insignia gets $1.8 billion bid from CC Capital, topping Bain offer
-
Form 8-K Bain Capital Private For: Dec 27
-
Form D Bain Capital XIV Access
-
Form D Bain Capital XIV Access
